This study identified three biomarkers (RPL14, SMARCD3, TCN1) through machine learning algorithms and explored their potential mechanisms in ARDS via ANN model construction, enrichment analysis, regulatory network construction, and drug prediction analysis. This evidence concerns the gene SMARCD3 and acute respiratory distress syndrome.